A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
NCT07489885 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2026-03-27
Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Conditions
Interventions
- DRUG
-
D-2570 Tablet
Active Treatment
- DRUG
-
Placebo Tablets
Identical Tablet
Sponsors & Collaborators
-
InventisBio Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-31
- Primary Completion
- 2027-08-31
- Completion
- 2027-12-31
- FDA Drug
- Yes
More Related Trials
-
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
NCT00770965 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
NCT07129382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
NCT05730725 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
NCT07432854 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis
NCT00669916 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis
NCT07008547 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis
NCT04999839 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
NCT04603027 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis
NCT06972888 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
NCT02931838 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
NCT05357755 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy
NCT00245765 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06077331 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis
NCT00805480 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
NCT02413229 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
NCT04316585 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject
NCT02303509 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
NCT07150988 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
NCT02982005 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
NCT01154101 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
NCT06176508 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
NCT07234591 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
NCT06058546 ·Status: RECRUITING ·Phase: PHASE2